| abstract |
Methods and kits for the prognosis of colorectal cancer. # The invention relates to methods for predicting the risk of relapse of patients with colorectal cancer, as well as to methods for providing personalized medicine to said patients, based on the Expression levels of the ACSL1, ACSL4 genes and, optionally, GCNT3, LPL, APOC1, SCD, whose expression products are involved in cellular energy metabolism. The invention also relates to kits for carrying out predictive and predictive medicine methods. |